Vericel Stock (NASDAQ: VCEL) stock price, news, charts, stock research, profile.
Open | $49.000 |
Close | - |
Volume / Avg. | 65.018K / 434.766K |
Day Range | 48.020 - 49.000 |
52 Wk Range | 30.180 - 53.050 |
Market Cap | $2.338B |
P/E Ratio | 4.852K |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 14.92% |
Days to Cover | 12.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vericel (NASDAQ: VCEL) through any online brokerage.
Other companies in Vericel’s space includes: Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX), PTC Therapeutics (NASDAQ:PTCT) and Dyne Therapeutics (NASDAQ:DYN).
The latest price target for Vericel (NASDAQ: VCEL) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 55.00 expecting VCEL to rise to within 12 months (a possible 14.32% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Vericel (NASDAQ: VCEL) is $48.11 last updated Today at May 14, 2024 at 1:16 PM EDT.
There are no upcoming dividends for Vericel.
Vericel’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for Vericel.
Vericel is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.